Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Perhach

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Chromatography|December 11, 1981
Determination of methyclothiazide in human plasma by high-performance liquid chromatographyC A Hartman, N Kucharczyk, R D Sofia, et al.
The Annals of Pharmacotherapy|December 1, 1994
Comment: warfarin-felbamate interactionP Glue, C R Banfield, R D Colucci, et al.
Pharmacology|January 1, 1982
Antagonism by meseclazone and other nonsteroidal anti-inflammatory drugs of bradykinin-induced bronchospasmW Diamantis, J E Harrison, J L Perhach, et al.
European Journal of Pharmacology|December 23, 1983
Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of actionN Chand, J Pillar, W Diamantis, et al.
Allergy|September 1, 1986
Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigsN Chand, K Nolan, W Diamantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1974
Aberrations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive ratsM S Amer, A W Gomoll, J L Perhach, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1984
Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cellsD A Fields, J Pillar, W Diamantis, et al.
Postgraduate Medical Journal|January 1, 1987
Clinical experience with flupirtine in the U.SF G McMahon, W F Arndt, J J Newton, et al.
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Epilepsia|August 1, 1997
Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsyR Sachdeo, S K Narang-Sachdeo, R C Shumaker, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Chromatography|December 11, 1981
Determination of methyclothiazide in human plasma by high-performance liquid chromatographyC A Hartman, N Kucharczyk, R D Sofia, et al.
The Annals of Pharmacotherapy|December 1, 1994
Comment: warfarin-felbamate interactionP Glue, C R Banfield, R D Colucci, et al.
Pharmacology|January 1, 1982
Antagonism by meseclazone and other nonsteroidal anti-inflammatory drugs of bradykinin-induced bronchospasmW Diamantis, J E Harrison, J L Perhach, et al.
European Journal of Pharmacology|December 23, 1983
Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of actionN Chand, J Pillar, W Diamantis, et al.
Allergy|September 1, 1986
Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigsN Chand, K Nolan, W Diamantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1974
Aberrations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive ratsM S Amer, A W Gomoll, J L Perhach, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1984
Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cellsD A Fields, J Pillar, W Diamantis, et al.
Postgraduate Medical Journal|January 1, 1987
Clinical experience with flupirtine in the U.SF G McMahon, W F Arndt, J J Newton, et al.
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Epilepsia|August 1, 1997
Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsyR Sachdeo, S K Narang-Sachdeo, R C Shumaker, et al.
Pageof 4